Jinhai Medical Technology Surges Over 14% on South Korean Investor Accumulation

Stock News07-21 16:02

Shares of Jinhai Medical Technology (02225) soared more than 14% during the trading session.

At the time of writing, the stock was up 14.64% to HK$4.15, with a turnover exceeding HK$147 million.

Data from the Securities Information Portal (SEIBro), operated by the Korea Securities Depository, indicates that South Korean investors have been increasing their holdings of Chinese assets with real capital over the past week, even as global technology stocks experienced significant corrections.

Within the Hong Kong market, targets including Jinhai Medical Technology received net purchases amounting to over a million US dollars.

The company specializes in providing comprehensive solutions for minimally invasive medical devices, such as high-end medical endoscopes.

Through sustained, in-depth research and development in endoscope technology in recent years, Jinhai has achieved several significant breakthroughs.

The company's Chief Marketing Officer, Mr. He Xiao, previously stated, "Over the next three years, we are continuously investing in areas including spine and surgical products. Particularly in the field of AI for minimally invasive spine surgery, we are also seeking a new breakthrough."

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1117175671?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 16:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1117175671","market":"fut","top_or_hot":-1,"title":"Jinhai Medical Technology Surges Over 14% on South Korean Investor Accumulation","media":"Stock News","content":"<p>Shares of <b>Jinhai Medical Technology</b> (<b>02225</b>) soared more than 14% during the trading session.<br><br>At the time of writing, the stock was up 14.64% to HK$4.15, with a turnover exceeding HK$147 million.<br><br>Data from the Securities Information Portal (SEIBro), operated by the Korea Securities Depository, indicates that South Korean investors have been increasing their holdings of Chinese assets with real capital over the past week, even as global technology stocks experienced significant corrections.<br><br>Within the Hong Kong market, targets including <b>Jinhai Medical Technology</b> received net purchases amounting to over a million US dollars.<br><br>The company specializes in providing comprehensive solutions for minimally invasive medical devices, such as high-end medical endoscopes.<br><br>Through sustained, in-depth research and development in endoscope technology in recent years, Jinhai has achieved several significant breakthroughs.<br><br>The company's Chief Marketing Officer, Mr. He Xiao, previously stated, \"Over the next three years, we are continuously investing in areas including spine and surgical products. Particularly in the field of AI for minimally invasive spine surgery, we are also seeking a new breakthrough.\"</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Jinhai Medical Technology Surges Over 14% on South Korean Investor Accumulation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJinhai Medical Technology Surges Over 14% on South Korean Investor Accumulation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-21 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of <b>Jinhai Medical Technology</b> (<b>02225</b>) soared more than 14% during the trading session.<br><br>At the time of writing, the stock was up 14.64% to HK$4.15, with a turnover exceeding HK$147 million.<br><br>Data from the Securities Information Portal (SEIBro), operated by the Korea Securities Depository, indicates that South Korean investors have been increasing their holdings of Chinese assets with real capital over the past week, even as global technology stocks experienced significant corrections.<br><br>Within the Hong Kong market, targets including <b>Jinhai Medical Technology</b> received net purchases amounting to over a million US dollars.<br><br>The company specializes in providing comprehensive solutions for minimally invasive medical devices, such as high-end medical endoscopes.<br><br>Through sustained, in-depth research and development in endoscope technology in recent years, Jinhai has achieved several significant breakthroughs.<br><br>The company's Chief Marketing Officer, Mr. He Xiao, previously stated, \"Over the next three years, we are continuously investing in areas including spine and surgical products. Particularly in the field of AI for minimally invasive spine surgery, we are also seeking a new breakthrough.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1150","symbol_name":"人力资源与就业服务","start_time":0,"source_url":"","article_id":"1117175671","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1117175671","pubTimestamp":1784620968,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shares of Jinhai Medical Technology (02225) soared more than 14% during the trading session.At the time of writing, the stock was up 14.64% to HK$4.15, with a turnover exceeding HK$147 million.Data...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1150":"人力资源与就业服务","BK4588":"碎股","BK4585":"ETF&股票定投概念","KCAI":"KraneShares China Alpha Index ETF","VXUS":"国际股票ETF-Vanguard","02225":"今海医疗科技"},"translate_title":"由于韩国投资者的积累，金海医疗科技股价飙升超过14%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02225":1,"VXUS":1,"KCAI":1},"content_text":"Shares of Jinhai Medical Technology (02225) soared more than 14% during the trading session.At the time of writing, the stock was up 14.64% to HK$4.15, with a turnover exceeding HK$147 million.Data from the Securities Information Portal (SEIBro), operated by the Korea Securities Depository, indicates that South Korean investors have been increasing their holdings of Chinese assets with real capital over the past week, even as global technology stocks experienced significant corrections.Within the Hong Kong market, targets including Jinhai Medical Technology received net purchases amounting to over a million US dollars.The company specializes in providing comprehensive solutions for minimally invasive medical devices, such as high-end medical endoscopes.Through sustained, in-depth research and development in endoscope technology in recent years, Jinhai has achieved several significant breakthroughs.The company's Chief Marketing Officer, Mr. He Xiao, previously stated, \"Over the next three years, we are continuously investing in areas including spine and surgical products. Particularly in the field of AI for minimally invasive spine surgery, we are also seeking a new breakthrough.\"","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1117175671","isCrawlerRequest":true}